Updated Monday, 11/16. US IPO market activity is picking back up ahead of the Thanksgiving holiday, with seven IPOs scheduled to raise $3.6 billion in the week ahead. Biotech research product provider ...read more
Five IPOs and 17 SPACs went public this past week. While new filing activity has slowed as the election approaches, four IPOs and four SPACs submitted initial filings. Leading security software provider McAfee (MCFE) priced...read more
Abcam, which sells biological reagents and tools for research, drug discovery, and diagnostics, raised $157 million by offering 8.9 million ADSs at $17.50, below the as-converted last close of $18.06 for its shares trading on the AIM (ABC). At pricing, the...read more
Abcam, which provides biological reagents and tools for research, drug discovery, and diagnostics, announced terms for its US IPO on Monday. The Cambridge, United Kingdom-based company plans to raise $148 million by offering 8.9 million ADSs at $16.52, the...read more
US IPO Week Ahead: 7 IPOs squeeze in before the Thanksgiving holiday
Updated Monday, 11/16. US IPO market activity is picking back up ahead of the Thanksgiving holiday, with seven IPOs scheduled to raise $3.6 billion in the week ahead. Biotech research product provider ...read more
US IPO Weekly Recap: McAfee leads a 5 IPO week
Five IPOs and 17 SPACs went public this past week. While new filing activity has slowed as the election approaches, four IPOs and four SPACs submitted initial filings. Leading security software provider McAfee (MCFE) priced...read more
UK-based research tool provider Abcam prices US IPO at $17.50
Abcam, which sells biological reagents and tools for research, drug discovery, and diagnostics, raised $157 million by offering 8.9 million ADSs at $17.50, below the as-converted last close of $18.06 for its shares trading on the AIM (ABC). At pricing, the...read more
UK-based research tool provider Abcam sets terms for $148 million US IPO
Abcam, which provides biological reagents and tools for research, drug discovery, and diagnostics, announced terms for its US IPO on Monday. The Cambridge, United Kingdom-based company plans to raise $148 million by offering 8.9 million ADSs at $16.52, the...read more